Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 48 studies | 75% ± 20% | |
pericyte | 38 studies | 52% ± 23% | |
smooth muscle cell | 33 studies | 47% ± 21% | |
connective tissue cell | 19 studies | 73% ± 24% | |
myofibroblast cell | 15 studies | 76% ± 19% | |
endothelial cell | 12 studies | 29% ± 15% | |
mesothelial cell | 11 studies | 63% ± 16% | |
glial cell | 6 studies | 38% ± 21% | |
adventitial cell | 5 studies | 84% ± 10% | |
Schwann cell | 4 studies | 36% ± 27% | |
adipocyte | 4 studies | 53% ± 36% | |
hepatic stellate cell | 3 studies | 29% ± 16% | |
abnormal cell | 3 studies | 45% ± 22% | |
macrophage | 3 studies | 43% ± 27% | |
epithelial cell | 3 studies | 60% ± 27% | |
B cell | 3 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 97% | 60732.31 | 443 / 459 | 95% | 1790.76 | 1061 / 1118 |
lung | 98% | 68094.01 | 569 / 578 | 83% | 682.68 | 960 / 1155 |
ovary | 100% | 84334.35 | 180 / 180 | 73% | 567.78 | 316 / 430 |
bladder | 100% | 67985.57 | 21 / 21 | 68% | 595.86 | 345 / 504 |
intestine | 87% | 40292.21 | 837 / 966 | 75% | 589.79 | 393 / 527 |
uterus | 99% | 92899.72 | 169 / 170 | 56% | 620.03 | 255 / 459 |
esophagus | 78% | 33830.97 | 1128 / 1445 | 75% | 662.83 | 138 / 183 |
skin | 84% | 213198.96 | 1515 / 1809 | 62% | 483.96 | 294 / 472 |
prostate | 95% | 46323.94 | 233 / 245 | 43% | 135.72 | 214 / 502 |
stomach | 56% | 19620.34 | 200 / 359 | 81% | 626.06 | 233 / 286 |
thymus | 85% | 26518.79 | 552 / 653 | 28% | 163.28 | 172 / 605 |
pancreas | 10% | 3222.28 | 34 / 328 | 91% | 1546.19 | 162 / 178 |
blood vessel | 99% | 120087.05 | 1328 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 77655.14 | 1178 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 64% | 13316.56 | 165 / 258 | 15% | 79.77 | 35 / 230 |
heart | 75% | 37821.92 | 648 / 861 | 0% | 0 | 0 / 0 |
kidney | 31% | 8713.84 | 28 / 89 | 35% | 182.12 | 311 / 901 |
tonsil | 0% | 0 | 0 / 0 | 60% | 504.53 | 27 / 45 |
spleen | 57% | 12067.59 | 137 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 31% | 130.15 | 9 / 29 |
liver | 4% | 1079.04 | 9 / 226 | 16% | 68.98 | 66 / 406 |
eye | 0% | 0 | 0 / 0 | 16% | 58.04 | 13 / 80 |
muscle | 8% | 1909.95 | 66 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 23.71 | 3 / 2642 | 8% | 64.70 | 55 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042476 | Biological process | odontogenesis |
GO_0085029 | Biological process | extracellular matrix assembly |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0070208 | Biological process | protein heterotrimerization |
GO_0030282 | Biological process | bone mineralization |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0001568 | Biological process | blood vessel development |
GO_0043589 | Biological process | skin morphogenesis |
GO_0001501 | Biological process | skeletal system development |
GO_0007266 | Biological process | Rho protein signal transduction |
GO_0030199 | Biological process | collagen fibril organization |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0032963 | Biological process | collagen metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005584 | Cellular component | collagen type I trimer |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0046332 | Molecular function | SMAD binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0002020 | Molecular function | protease binding |
GO_0048407 | Molecular function | platelet-derived growth factor binding |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | COL1A2 |
Protein name | COL1A2 protein Collagen, type I, alpha 2, isoform CRA_c (Epididymis secretory sperm binding protein) Alpha-2 type I collagen Alpha 2 type I procollagen Collagen type I alpha 2 Mutant collagen alpha 2(I) chain CB peptide alpha 2CB4 Collagen type I alpha 2 isoform 1 Uncharacterized protein COL1A2 Collagen type I alpha 2 isoform 5 Collagen alpha-2(I) chain (Alpha-2 type I collagen) |
Synonyms | hCG_1686428 |
Description | FUNCTION: Type I collagen is a member of group I collagen (fibrillar forming collagen). FUNCTION: Type I collagen is a member of group I collagen (fibrillar forming collagen). . FUNCTION: Type I collagen is a member of group I collagen (fibrillar forming collagen). . |
Accessions | Q16033 A2TIK1 A0A0S2Z3K0 P08123 A0A384MDU2 A0A0S2Z3H5 Q75N18 Q16452 Q7KZ71 Q14036 ENST00000297268.11 |